source
- Westlake-backed Vedana Therapeutics raises $46M to develop anti-PACAP migraine prevention drugsVedana Therapeutics, a new biotech formed out of stealth, announced it has secured $46 million in financing backed by Westlake. The capital will be used to advance its anti-PACAP antibody program a…
- Physician warns of surge in congenital syphilis cases, highest in decadesThe CDC reported nearly 4,000 cases of congenital syphilis in 2024, the most since the mid-1950s. About 5-10% of those infants are stillborn or die shortly after birth, and many survivors face life…